NanoVibronix Inc (NAOV) just unveiled an update.
NanoVibronix, Inc. has struck a deal with Veranex, Inc. for research and development services to enhance its UroShield and PainShield products. Valued at around $1.1 million, this 50-week contract includes provisions for adjustments and possible termination. Payments are monthly, with late fees applied, and either party can terminate the agreement under specific conditions, including payment issues or inability to perform duties. The partnership’s details are laid out in a press release but are not required to be updated by the company.
See more data about NAOV stock on TipRanks’ Stock Analysis page.
